Notice ID: 5ff1aa1bdb3b48f6b3a9118f86cfac54Combined Synopsis/Solicitation
6505--Supplemental Radiopharmaceuticals SAVAHCS
Archived on May 12, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:00 AM UTC−07:00
- Posted
- April 3, 2024
- Notice type
- Combined Synopsis/Solicitation
Notice details
- Office
- 262-NETWORK CONTRACT OFFICE 22 (36C262)
- Place of performance
- SAVAHCS Nuclear Medicine Building 38, Room A 109 3601 S 6th Avenue, Tucson, 85723
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 36C26224Q0946
- Notice ID
- 5ff1aa1bdb3b48f6b3a9118f86cfac54
Description
This is a combined synopsis/solicitation is unrestricted/full and open for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26224Q0946 The Southern Arizona VA Healthcare System (SAVAHCS) located in Tucson, AZ has a purchase requirement for radiopharmaceuticals called DaTscan and Vizamyl for base plus option four years. See section B.2 Statement of Work for more details. NOTE: Potential offers must be aware that the items being acquired are procured as Brand Name or Equal. For those items that are or equal , a description of the salient characteristics are outlined below. The FAR Clause 52.211-6 Brand Name or Equal applies to this acquisition. Any items quoted as equal not confirming to the requirements of clause 52.211-6 will be considered non- responsive and not considered for award. No remanufactures or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM. PoP Item # Description/Part Number* Qty UOM Base 0001 DaTscan (Ioflupane I 123) injection 5mCi 12 EA Base 0002 Vizamyl (Flutemetamol F18) injection 42 EA OY1 1001 DaTscan (Ioflupane I 123) injection 5mCi 24 EA OY1 1002 Vizamyl (Flutemetamol F18) injection 84 EA OY2 2001 DaTscan (Ioflupane I 123) injection 5mCi 24 EA OY2 2002 Vizamyl (Flutemetamol F18) injection 84 EA OY3 3001 DaTscan (Ioflupane I 123) injection 5mCi 24 EA OY3 3002 Vizamyl (Flutemetamol F18) injection 84 EA OY4 4001 DaTscan (Ioflupane I 123) injection 5mCi 24 EA OY4 4002 Vizamyl (Flutemetamol F18) injection 84 EA The solicitation will be in accordance with FAR Part 12, 13, and 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412, Size Standard 1,300 Employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award. Key solicitation milestones are: Submit any questions regarding this procurement via email to hestia.sim@va.gov no later than 10am Pacific Local Time Monday, April 8, 2024. No questions will be answered after this date/time unless determined to be in the best interest of the Government as determined by the Contracting Officer. Telephonic questions will not be accepted or returned. RFI responses will be responded to as necessary in amendment format which will be posted to contract opportunities at http://SAM.gov. Due to time constraints, responses to the solicitation shall be due on Friday, April 12, 2024 at 10:00 Pacific Time. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Correspondence or questions may be directed to Hestia Sim, Contracting Specialist at Hestia.Sim@va.gov with " 36C26224Q0946, Supplemental Radiopharmaceuticals SAVAHCS in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired.
Award Overview
Possible prior contract
Inferred, not confirmedInferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.
Vendor
OPTUM PHARMACY 801, INC.Contract end date
Sep 30, 2023
NAICS
325412
Agency
Department of Veterans Affairs
Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.
Contacts
Contracting Officer
Primary Contact
Hestia Sim
Contract Specialist
Documents
No documents available.
Lifecycle
Solicitation:
36C26224Q0946- Combined Synopsis
- Combined SynopsisCurrentApr 3, 2024
6505--Supplemental Radiopharmaceuticals SAVAHCS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C26224Q0946
Archive Date
May 12, 2024
Office Address
Gilbert, AZ, 85297